Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
Background: The role of the norepinephrine transporter (NET) has received increased focus in recent studies on the pathogenesis of attention-deficit/hyperactivity disorder (ADHD). The predictive value for pharmacological treatment and its link to other health or social limitations has been little-st...
Main Authors: | Jue Huang, Nicole Mauche, Michael Rullmann, Christine Ulke, Georg-Alexander Becker, Marianne Patt, Franziska Zientek, Swen Hesse, Osama Sabri, Maria Strauß |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/8/965 |
Similar Items
-
Effectiveness of Psychostimulant and Non-Psychostimulant Drug Therapy in the Attention Deficit Hyperactivity Disorder
by: Adriana Cojocaru, et al.
Published: (2021-01-01) -
Cumulative exposure to ADHD medication is inversely related to hippocampus subregional volume in children
by: Nellie H. Fotopoulos, et al.
Published: (2021-01-01) -
Interaction of Diamine Oxidase with Psychostimulant Drugs for ADHD Management
by: Yaiza Tobajas, et al.
Published: (2023-07-01) -
Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis
by: W. David Lohr, et al.
Published: (2021-04-01) -
Understanding the Diversity of Pharmacotherapeutic Management of ADHD With Co-occurring Autism: An Australian Cross-Sectional Survey
by: Olivia J. Mellahn, et al.
Published: (2022-06-01)